Phase 1/2 Study of Enzastaurin in Newly Diagnosed Glioblastoma Multiforme (GBM) and Gliosarcoma (GS) Patients

Clinical trial NCT00402116 · COMPLETED

Trial details

NCT number: NCT00402116
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Glioblastoma Glioblastoma Multiforme Gliosarcoma

Start date: 2006-09-01
Primary completion: 2009-12-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.